2. Introduction to Providing Medication Assisted Treatment through Medication Units Wilma Townsend DPT, Team Leader November 20, 2014

3. Objectives (1) increase the field’s knowledge of medication units and their usefulness and barriers to implementation; (2) demonstrate how medication units increase treatment capacity and access to care, (3) provide guidance on current demographic settings where medication units currently exist and thrive and (4) discuss the cost benefits of Implementing medication units to expand access to care.

4. What you will hear today The rules and regulations from SAMHSA and DEA The experience and role of the State in the development of medication units The experiences, successes and barriers in starting a medication units from the program’s perspectives The cost benefits of a medication unit

5. What is stated in the Code of Federal Regulations (1 of 2) Medication Units are facilities established as part of, but geographically separate from, an opioid treatment program from which licensed private practitioners or community pharmacists dispense or administer an opioid agonist treatment medication or collect samples for drug testing or analysis. CFR 42, part 8, 8.2, 8.12

6. What is stated in the Code of Federal Regulations (2 of 2) Certified OTPs may establish medication units that are authorized to dispense opioid agonist treatment medications for observed ingestion. Before establishing a medication unit, a certified OTP must notify SAMHSA by submitting form SMA-162 The OTP must also comply with the provisions of 21 CFR part 1300 Medication units shall comply with all pertinent state laws and regulations CFR 42, part 8, Subpart B, 8.11 (i)

7. Survey Findings 34 States and Puerto Rico responded 2 States (KY, MA) and Puerto Rico have Medication Units KY 4 units, PR 2 units, MA unspecified 5 States (ME, MN, OR, WA, WI) indicated that Medicaid reimburse for client travel to access an OTP Over 60% of States reported that some clients travel over 76 miles 8 states reported policies or issues that would prevent development of MU 20 States reported that they would like to have more information and technical assistance on MU Compiled by NASADAD

8. Cost Some States have Medicaid reimburse for transportation for transporting patients to OTPs This have been raised as a factor in some state Medicaid plans States may want to evaluate the cost of Medicaid reimbursement of transporting patients vs. the cost of establishing medication unit

9. Introduction of Presenters DEA – Mr. James Arnold, Chief Policy Unit Kentucky’s State Opioid Treatment Authority – Mr. Mark Fisher Pinnacle Treatment Centers’ medication unit – Ms. Holly Broce

10. Instructions Presentation Questions at the end of each presentation In the chat session you can type in your questions If we do not get to your questions we will have the presenters to answer them in writing after the presentation and we will put them on the DPT website with the slides of this webinar

11. Evaluation Please complete the evaluation at the end of the webinar Let us know if there are other topics you would like for us to present in the future.